Literature DB >> 20819413

Tumour necrosis factor-alpha polymorphisms and hepatocellular carcinoma: a meta-analysis.

H Qin1, B Liu, T Shi, Y Liu, Y Sun, Y Ma.   

Abstract

The genetic basis of susceptibility to hepatocellular carcinoma (HCC) is poorly understood. To summarize the quantitative association between polymorphisms of the tumour necrosis factor-alpha (TNFA) gene and HCC, a meta-analysis of relevant studies was performed. Ten case-control studies involving 1421 HCC cases were identified from the Medline, Embase and Current Contents databases. Combined results based on all studies showed that patients with HCC had a significantly lower frequency of the TNFA gene polymorphism -308GG than healthy controls. When stratifying for race, results were similar among Asians and Caucasians. When comparing with hepatitis B virus infection cases, no statistical association was found. This meta-analysis suggests that TNFA -308GG gene polymorphism is associated with a modest decrease in the risk of HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819413     DOI: 10.1177/147323001003800304

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  8 in total

Review 1.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

Review 2.  Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.

Authors:  Yonggang Wei; Fei Liu; Bo Li; Xi Chen; Yu Ma; Lvnan Yan; Tianfu Wen; Mingqing Xu; Wentao Wang; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2011-02-19       Impact factor: 3.199

3.  Human genetic variation and the risk of hepatocellular carcinoma development.

Authors:  Sayeh Ezzikouri; Soumaya Benjelloun; Pascal Pineau
Journal:  Hepatol Int       Date:  2013-08-02       Impact factor: 6.047

4.  Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.

Authors:  Suk Pyo Shin; Nam Keun Kim; Ju Hwan Kim; Ju Ho Lee; Jung Oh Kim; Sung Hwan Cho; Hana Park; Mi Na Kim; Kyu Sung Rim; Seong Gyu Hwang
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

Review 5.  Epidemiology of hepatocellular carcinoma: consider the population.

Authors:  Sahil Mittal; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

6.  The Tumor Necrosis Factor-α-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis.

Authors:  Qing Hu; Guo-Guang Lou; Ying-Chao Liu; Le Qian; Bo-Dong Lv
Journal:  Curr Ther Res Clin Exp       Date:  2014-09-27

7.  Vitamin D and Tumor Necrosis Factor-Alpha Receptor Gene Polymorphisms in Various Hepatitis B Clinical Conditions in Turkey.

Authors:  Semra Tuncbilek; Kemalettin Aydin; Kenan Hizel
Journal:  Gastroenterology Res       Date:  2013-10-31

8.  Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Bang-De Xiang; Liang Ma; Xue-Mei You; Le-Qun Li; Gui-Sheng Xie
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.